Search

Search Constraints

You searched for: Author/Creator Antoniou, Antonis

Search Results

1. 401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention. (4th December 2020)

2. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Issue 1 (December 2015)

3. Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore. Issue 5 (2nd April 2021)

4. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. (January 2019)

5. Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset. (2nd October 2018)

6. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Issue 1 (December 2016)

7. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32, 295 women. Issue 1 (December 2016)

8. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Issue 1 (December 2016)

9. Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study. (December 2018)

10. The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening. (15th August 2021)